Skip to content
healthcare.dev

Tizanidine

NDC 71610-228, Tizanidine, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-228
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091283
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-228 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
71610-228-307161002283030 TABLET in 1 BOTTLE, PLASTIC (71610-228-30)
71610-228-537161002285360 TABLET in 1 BOTTLE, PLASTIC (71610-228-53)
71610-228-607161002286090 TABLET in 1 BOTTLE, PLASTIC (71610-228-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ea242c7d-b101-4197-8e65-b2b079e3b2b6

Use it

Look up 71610-228 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-228 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-228. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.